ArticleInternational journal of health geographics2026
EpiGIS pro: an AI-powered geospatial intelligence platform for integrated disease surveillance and predictive analytics.
Article in International journal of health geographics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGlobal infectious disease surveillance requires timely integration of heterogeneous data sources. Existing platforms typically address only one dimension, leaving cross-domain correlations unexplored. This study presents EpiGIS Pro, an AI-powered geospatial platform that consolidates automated disease event extraction, environmental monitoring, mobility analysis, and predictive analytics within a single web-based framework, providing a shared data infrastructure for future cross-domain modeling.
methodsEpiGIS Pro employs a modular multi-application architecture built on Django REST Framework with PostGIS spatial extensions. Disease intelligence is automated from six source categories using Claude AI (Anthropic) for structured extraction with standardized epidemiological metadata. Environmental data, traffic congestion indicators, and international flight route data are ingested via scheduled Celery Beat tasks. Machine learning modules include Prophet-based time-series forecasting with multiplicative seasonality for WHO FluNet data, seasonal Z-score anomaly detection, and effective reproduction number (R_t) estimation. Semantic search is enabled through Voyage AI embeddings stored in pgvector-indexed PostgreSQL. A systematic evaluation framework covers six analytical dimensions across 9 countries spanning 6 years of data.
resultsThe platform integrates 327,000 + records across six data domains. Claude AI extraction processed 353 disease event articles from 56 countries with 92.4% success and 100% completeness for disease type, severity, and priority fields. Using 2,868 WHO FluNet records across 9 countries (2019-2026), seasonality analysis correctly identified hemisphere-concordant peak timing in all 7 evaluated countries. Prophet multiplicative forecasting reduced RMSE by 21-29% compared to the seasonal naive baseline for the United States, and consistently outperformed log-transformed Prophet across all countries and horizons. R_t estimation demonstrated epidemiologically consistent patterns, with onset-period R_t exceeding trough-period R_t in Australia (1.27 vs. 1.09) and Japan (1.80 vs. 1.08). Cross-border risk assessment computed 4,828 flight corridor risk scores by linking disease activity with 633 international aviation routes.
conclusionsEpiGIS Pro demonstrates that consolidating AI-driven event extraction, multi-source environmental and mobility data, and geospatial analytics within a unified platform enhances situational awareness for global disease surveillance. The modular architecture and reproducible evaluation framework position EpiGIS Pro as both a practical surveillance tool and a research testbed for computational epidemiology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.